Anti-Aging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Device ; By Treatment ; By Demography ; By Region

Description

Global Anti-Aging Market Size Expanding to Cross USD 108 Billion by 2029.

Global anti-aging market is flourishing due to the growing popularity of anti-aging products and treatments along with consumer awareness coupled with an increase in disposable income.

BlueWeave Consulting, a leading strategic consulting and market research firm, estimated the global anti-aging market size at USD 66.09 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global anti-aging market size to grow at a CAGR of 7.5% reaching a value of USD 108.34 billion by 2029. A variety of factors, including the rising elderly population, technological advancements, and increased public awareness of cutting-edge cosmetic procedures, all contribute to the growth. Consumers are now more willing to spend money on these personal care products due to the prevalence of at-home devices for skin rejuvenation, cellulite reduction, wrinkle reduction, and microdermabrasion. The development of these transportable, user-friendly products is methodical.

Global Anti-Aging Market - Overview:

The human body deteriorates over time due to a series of biochemical processes known as biochemical ageing, which also has an impact on one's physical fitness, general well-being, and appearance. Anti-aging refers to the process of limiting or postponing these changes using a range of products and services. Today, success in a variety of spheres of life depends on having a positive physical personality. Consumers of all ages are becoming more self-conscious, which has increased the demand for anti-aging goods and services.

Opportunity: Increasing awareness about aging signs

The younger generation's increased awareness of these products for the body and skin is driving the global market for anti-aging products. People are more likely to take care of their skin because skin problems are becoming more common as a result of pollution, poor eating habits, alcohol abuse, and other factors. People's increased efforts to appear young and healthy is one of the factors driving demand for various anti-aging goods such as creams, lotions, and gels. Many people opt for various skin care procedures and cosmetic enhancements to improve their skin and appearance, reduce pigmentation, repair UV damage, and so on.

Challenge: High cost of raw materials

Hyaluronic acids are natural substances that are used as raw materials to make anti-wrinkle products. A recent news report claims that the cost of goods sold, which includes packaging and raw materials, has increased. The main plastic material used in the packaging has a sizable impact on the finished product's price. Prices for products utilizing cutting-edge science and technology, such as synthetics, UV agents, fatty acids, SPF compounds, and essential oils, have increased, according to the same survey.

Impact of COVID-19 on Global Anti-Aging Market

COVID-19, the global pandemic, had a significant impact on all aspects of the healthcare industry. According to a study published in Aesthetic Plastic Surgery 2020, 17.7 million cosmetic procedures were performed in 2018, a 2% increase from the previous year, highlighting the rising trend in cosmetic procedures. However, the number of cosmetic procedures performed in the US during the COVID-19 pandemic in 2020 was minimal to none (mid-March to mid-June). Wearing a face mask, which is especially important during the current pandemic, had negative effects on skin, according to a research study conducted by Amorepacific Research Institute and Technology, and suggested that skin covered with face masks should be treated extra carefully due to certain changes in skin characteristics.

Global Anti-Aging Market - By Treatment

The global anti-aging market based on treatment is segmented into Hair Restoration, Anti-Pigmentation, Adult Acne, Liposuction, Breast Augmentation, and Chemical Peel. The hair restoration segment dominates the anti-aging market. The main cause is expected to be the rise in hair treatments due to people going balder and losing more hair. The hair restoration sector dominates the anti-aging market. As baldness and hair loss among adults become more common, an increase in the number of hair treatments will be the main contributor. The anti-aging market's adult acne therapy segment will experience the fastest growth. Inflammation and clogged pores are the primary causes of almost all forms of adult acne. As a result, the use of adult acne therapy as an anti-aging treatment.

Competitive Landscape:

The global anti-aging market is fragmented, with numerous players in the market. Key players dominating the global anti-aging market include Unilever Group, GALDERMA LABORATORIES L.P., Procter & Gamble (P&G) Company, Nu Skin Enterprises Inc., Hologic Inc., Pierre Fabre S.A., Shiseido Company Limited, Candela Corporation, Home Skinovations Ltd., Estee Lauder, Johnson & Johnson, ZO Skin Health, Inc., L'Oreal Paris, Beiersdorf, and PHYTOMER. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisition to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Anti-Aging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Anti-Aging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC1817

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Anti-Aging Market Insights

3.1. Industry Value Chain Analysis
- 3.1.1. DROC Analysis
- 3.1.2. Growth Drivers
  - 3.1.2.1. Increase in Disposable Income
  - 3.1.2.2. Increasing Awareness of Aging Signs in Young Generations
  - 3.1.2.3. Growing Demand for Anti-Aging Products
- 3.1.3. Restraints
  - 3.1.3.1. High Cost of Raw Materials
- 3.1.4. Opportunities
  - 3.1.4.1. Advancements in Technology
- 3.1.5. Challenges
3.2. Technology Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of New Entrants
- 3.4.4. Threat of Substitutes
- 3.4.5. Intensity of Rivalry

4. Global Anti-Aging Market Overview

4.1. Market Size & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
- 4.2.1. By Product
  - 4.2.1.1. Anti-Wrinkle
  - 4.2.1.2. Hair Color
  - 4.2.1.3. UV Absorbers
  - 4.2.1.4. Anti-Stretch Marks
- 4.2.2. By Device
  - 4.2.2.1. Radiofrequency
  - 4.2.2.2. Laser
  - 4.2.2.3. Anti-Cellulite
  - 4.2.2.4. Microdermabrasion
  - 4.2.2.5. Others
- 4.2.3. By Treatment
  - 4.2.3.1. Hair Restoration
  - 4.2.3.2. Anti-Pigmentation
  - 4.2.3.3. Anti-Adult Acne
  - 4.2.3.4. Liposuction
  - 4.2.3.5. Breast Augmentation
  - 4.2.3.6. Chemical Peel
- 4.2.4. By Demography
  - 4.2.4.1. Generation X
  - 4.2.4.2. Baby Boomer
  - 4.2.4.3. Generation Y
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia Pacific (APAC)
  - 4.2.5.4. Latin America (LATAM)
  - 4.2.5.5. Middle East and Africa (MEA)

5. North America Anti-Aging Market

5.1. Market Size & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Device
- 5.2.3. By Treatment
- 5.2.4. By Demography
- 5.2.5. By Country
  - 5.2.5.1. US
  - 5.2.5.1.1. By Product
  - 5.2.5.1.2. By Device
  - 5.2.5.1.3. By Treatment
  - 5.2.5.1.4. By Demography
  - 5.2.5.2. Canada
  - 5.2.5.2.1. By Product
  - 5.2.5.2.2. By Device
  - 5.2.5.2.3. By Treatment
  - 5.2.5.2.4. By Demography

6. Europe Anti-Aging Market

6.1. Market Size & Forecast, 2019-2029
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Device
- 6.2.3. By Treatment
- 6.2.4. By Demography
- 6.2.5. By Country
  - 6.2.5.1. Germany
  - 6.2.5.1.1. By Product
  - 6.2.5.1.2. By Device
  - 6.2.5.1.3. By Treatment
  - 6.2.5.1.4. By Demography
  - 6.2.5.2. UK
  - 6.2.5.2.1. By Product
  - 6.2.5.2.2. By Device
  - 6.2.5.2.3. By Treatment
  - 6.2.5.2.4. By Demography
  - 6.2.5.3. Italy
  - 6.2.5.3.1. By Product
  - 6.2.5.3.2. By Device
  - 6.2.5.3.3. By Treatment
  - 6.2.5.3.4. By Demography
  - 6.2.5.4. France
  - 6.2.5.4.1. By Product
  - 6.2.5.4.2. By Device
  - 6.2.5.4.3. By Treatment
  - 6.2.5.4.4. By Demography
  - 6.2.5.5. Spain
  - 6.2.5.5.1. By Product
  - 6.2.5.5.2. By Device
  - 6.2.5.5.3. By Treatment
  - 6.2.5.5.4. By Demography
  - 6.2.5.6. The Netherlands
  - 6.2.5.6.1. By Product
  - 6.2.5.6.2. By Device
  - 6.2.5.6.3. By Treatment
  - 6.2.5.6.4. By Demography
  - 6.2.5.7. Rest of Europe
  - 6.2.5.7.1. By Product
  - 6.2.5.7.2. By Device
  - 6.2.5.7.3. By Treatment
  - 6.2.5.7.4. By Demography

7. Asia-Pacific Anti-Aging Market

7.1. Market Size & Forecast, 2019-2029
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Device
- 7.2.3. By Treatment
- 7.2.4. By Demography
- 7.2.5. By Country
  - 7.2.5.1. China
  - 7.2.5.1.1. By Product
  - 7.2.5.1.2. By Device
  - 7.2.5.1.3. By Treatment
  - 7.2.5.1.4. By Demography
  - 7.2.5.2. India
  - 7.2.5.2.1. By Product
  - 7.2.5.2.2. By Device
  - 7.2.5.2.3. By Treatment
  - 7.2.5.2.4. By Demography
  - 7.2.5.3. Japan
  - 7.2.5.3.1. By Product
  - 7.2.5.3.2. By Device
  - 7.2.5.3.3. By Treatment
  - 7.2.5.3.4. By Demography
  - 7.2.5.4. South Korea
  - 7.2.5.4.1. By Product
  - 7.2.5.4.2. By Device
  - 7.2.5.4.3. By Treatment
  - 7.2.5.4.4. By Demography
  - 7.2.5.5. Australia & New Zealand
  - 7.2.5.5.1. By Product
  - 7.2.5.5.2. By Device
  - 7.2.5.5.3. By Treatment
  - 7.2.5.5.4. By Demography
  - 7.2.5.6. Indonesia
  - 7.2.5.6.1. By Product
  - 7.2.5.6.2. By Device
  - 7.2.5.6.3. By Treatment
  - 7.2.5.6.4. By Demography
  - 7.2.5.7. Malaysia
  - 7.2.5.7.1. By Product
  - 7.2.5.7.2. By Device
  - 7.2.5.7.3. By Treatment
  - 7.2.5.7.4. By Demography
  - 7.2.5.8. Singapore
  - 7.2.5.8.1. By Product
  - 7.2.5.8.2. By Device
  - 7.2.5.8.3. By Treatment
  - 7.2.5.8.4. By Demography
  - 7.2.5.9. Philippines
  - 7.2.5.9.1. By Product
  - 7.2.5.9.2. By Device
  - 7.2.5.9.3. By Treatment
  - 7.2.5.9.4. By Demography
  - 7.2.5.10. Vietnam
  - 7.2.5.10.1. By Product
  - 7.2.5.10.2. By Device
  - 7.2.5.10.3. By Treatment
  - 7.2.5.10.4. By Demography
  - 7.2.5.11. Rest of APAC
  - 7.2.5.11.1. By Product
  - 7.2.5.11.2. By Device
  - 7.2.5.11.3. By Treatment
  - 7.2.5.11.4. By Demography

8. Latin America Anti-Aging Market

8.1. Market Size & Forecast, 2019-2029
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Device
- 8.2.3. By Treatment
- 8.2.4. By Demography
- 8.2.5. By Country
  - 8.2.5.1. Brazil
  - 8.2.5.1.1. By Product
  - 8.2.5.1.2. By Device
  - 8.2.5.1.3. By Treatment
  - 8.2.5.1.4. By Demography
  - 8.2.5.2. Mexico
  - 8.2.5.2.1. By Product
  - 8.2.5.2.2. By Device
  - 8.2.5.2.3. By Treatment
  - 8.2.5.2.4. By Demography
  - 8.2.5.3. Argentina
  - 8.2.5.3.1. By Product
  - 8.2.5.3.2. By Device
  - 8.2.5.3.3. By Treatment
  - 8.2.5.3.4. By Demography
  - 8.2.5.4. Peru
  - 8.2.5.4.1. By Product
  - 8.2.5.4.2. By Device
  - 8.2.5.4.3. By Treatment
  - 8.2.5.4.4. By Demography
  - 8.2.5.5. Rest of LATAM
  - 8.2.5.5.1. By Product
  - 8.2.5.5.2. By Device
  - 8.2.5.5.3. By Treatment
  - 8.2.5.5.4. By Demography

9. Middle East & Africa Anti-Aging Market

9.1. Market Size & Forecast, 2019-2029
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Device
- 9.2.3. By Treatment
- 9.2.4. By Demography
- 9.2.5. By Country
  - 9.2.5.1. Saudi Arabia
  - 9.2.5.1.1. By Product
  - 9.2.5.1.2. By Device
  - 9.2.5.1.3. By Treatment
  - 9.2.5.1.4. By Demography
  - 9.2.5.2. UAE
  - 9.2.5.2.1. By Product
  - 9.2.5.2.2. By Device
  - 9.2.5.2.3. By Treatment
  - 9.2.5.2.4. By Demography
  - 9.2.5.3. Qatar
  - 9.2.5.3.1. By Product
  - 9.2.5.3.2. By Device
  - 9.2.5.3.3. By Treatment
  - 9.2.5.3.4. By Demography
  - 9.2.5.4. Kuwait
  - 9.2.5.4.1. By Product
  - 9.2.5.4.2. By Device
  - 9.2.5.4.3. By Treatment
  - 9.2.5.4.4. By Demography
  - 9.2.5.5. South Africa
  - 9.2.5.5.1. By Product
  - 9.2.5.5.2. By Device
  - 9.2.5.5.3. By Treatment
  - 9.2.5.5.4. By Demography
  - 9.2.5.6. Nigeria
  - 9.2.5.6.1. By Product
  - 9.2.5.6.2. By Device
  - 9.2.5.6.3. By Treatment
  - 9.2.5.6.4. By Demography
  - 9.2.5.7. Algeria
  - 9.2.5.7.1. By Product
  - 9.2.5.7.2. By Device
  - 9.2.5.7.3. By Treatment
  - 9.2.5.7.4. By Demography
  - 9.2.5.8. Rest of MEA
  - 9.2.5.8.1. By Product
  - 9.2.5.8.2. By Device
  - 9.2.5.8.3. By Treatment
  - 9.2.5.8.4. By Demography

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Anti-Aging Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Anti-Aging Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. Unilever Group
12.2. GALDERMA LABORATORIES L.P.
12.3. Procter & Gamble (P&G) Company
12.4. Nu Skin Enterprises Inc.
12.5. Hologic Inc.
12.6. Pierre Fabre S.A.
12.7. Shiseido Company Limited
12.8. Candela Corporation
12.9. Home Skinovations Ltd.
12.10. Estee Lauder
12.11. Johnson & Johnson
12.12. ZO Skin Health, Inc.
12.13. L'Oreal Paris
12.14. Beiersdorf
12.15. PHYTOMER
12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations